Lab Reference Library / Pregnenolone Hormones & Reproductive

Pregnenolone

Pregnenolone · Mother Hormone · Steroid Precursor

Reference range, optimal functional medicine levels, and why pregnenolone is the master precursor steroid from which all other steroid hormones are synthesized, how declining pregnenolone with age underlies multi-hormone deficiency patterns, and why it has direct neurosteroid effects on memory, cognition, and mood independent of downstream hormone conversion.

Steroid PrecursorNeurosteroid

FM Optimal50 to 200 ng/dL

Standard Reference10 to 230 ng/dL

Age-Related DeclinePeak at age 30 to 35

Unitsng/dL

← Back to Lab Reference Library

Category: Hormones & Reproductive | Also known as: Pregnenolone Sulfate, 3-beta-Hydroxypregn-5-en-20-one, Mother Hormone, Steroid Precursor

1. What This Test Measures

Pregnenolone is the first steroid produced in the steroidogenesis cascade, synthesized from cholesterol by the mitochondrial CYP11A1 enzyme (cholesterol side-chain cleavage enzyme, P450scc) in the adrenal cortex, gonads, brain, and liver. This conversion is the rate-limiting and most highly regulated step in all steroid hormone biosynthesis, requiring not only the CYP11A1 enzyme but also adequate cholesterol delivery into the inner mitochondrial membrane by the steroidogenic acute regulatory protein (StAR), mitochondrial electron transport chain function to provide the reducing equivalents for the hydroxylation reaction, and adequate precursor substrates including cholesterol itself, NADPH, and molecular oxygen. The result is a 21-carbon steroid that contains neither the full glucocorticoid, mineralocorticoid, androgenic, nor estrogenic structural features that characterize its many downstream products, yet provides the biosynthetic starting material for all of them.

From pregnenolone, steroidogenesis branches into two primary pathways. The delta-5 pathway converts pregnenolone to 17-alpha-hydroxypregnenolone, then to DHEA, then to androstenediol and testosterone. The delta-4 pathway converts pregnenolone to progesterone (via 3-beta-HSD), then to 17-alpha-hydroxyprogesterone, then to androstenedione, then to testosterone; from progesterone the glucocorticoid branch produces cortisol, and the mineralocorticoid branch produces aldosterone. The specific proportions converted through each branch depend on the relative enzymatic activity of CYP17A1 (17-alpha-hydroxylase), 3-beta-HSD, and other pathway enzymes in a given tissue and individual, and these proportions can shift with age, stress, nutritional status, and inflammation.

Beyond its role as a steroid precursor, pregnenolone is itself a potent neurosteroid, produced locally in the brain by oligodendrocytes and astrocytes and acting directly on GABA-A receptors (as a negative allosteric modulator), NMDA receptors (as a positive modulator), and sigma-1 receptors (as an agonist). These direct neurosteroid effects produce cognitive enhancement, memory support, and mood modulation independent of pregnenolone's conversion to downstream hormones, making pregnenolone a clinically distinct compound from the steroid hormones it precedes in the biosynthetic cascade.

2. Reference Range and Optimal Levels

Age Group	Standard Reference	FM Optimal	Interpretation
Adults 20 to 30 years	50 to 200 ng/dL	100 to 180 ng/dL	Peak steroidogenic capacity; adequate precursor pool for all downstream hormone synthesis
Adults 40 to 50 years	30 to 150 ng/dL	80 to 150 ng/dL	Moderate decline; supplement to maintain adequate precursor pool if low-normal
Adults above 60 years	10 to 100 ng/dL	60 to 120 ng/dL	Significant age-related decline; below 50 ng/dL commonly associated with multi-hormone deficiency
Women (cycle-variable)	Context-dependent	Same age ranges above	Rises slightly post-ovulation; interpret alongside DHEA-S, progesterone, and estradiol

Serum pregnenolone measurement requires careful specimen handling; pregnenolone is lipophilic and requires appropriate collection tube (no gel separator tubes) and prompt separation. Pregnenolone sulfate (the sulfated storage form) can be measured as an alternative or complement to free pregnenolone; sulfated pregnenolone has a longer half-life and less diurnal variation, providing a more stable measurement. LC-MS/MS provides superior accuracy over immunoassay for pregnenolone at clinical concentrations. Not all commercial laboratories offer pregnenolone; specialty hormone panels or DUTCH-adjacent urinary steroid metabolomics panels provide the most complete steroidogenesis context.

3. Pregnenolone Decline With Aging: The Steroidogenic Cascade Consequence

Because pregnenolone is the universal steroid precursor, its age-related decline creates a downstream depletion of all steroid hormone classes simultaneously, contributing to the multi-hormone deficiency patterns that characterize biological aging.

Serum pregnenolone peaks in the mid-20s to mid-30s and then declines at approximately 1 to 2% per year, mirroring the pattern of DHEA-S (which is directly downstream of pregnenolone via the delta-5 pathway). By age 70, pregnenolone levels are typically 30 to 50% of peak values. This declining pregnenolone production reduces the substrate available for DHEA, progesterone, cortisol, and ultimately testosterone and estradiol synthesis. The practical clinical consequence is that a 65-year-old patient with low testosterone, low DHEA-S, low progesterone, and relative adrenal cortisol response impairment may have a single upstream driver: reduced pregnenolone production from declining mitochondrial CYP11A1 activity in the adrenal cortex. Supplementing individual downstream hormones (testosterone, DHEA, progesterone) addresses symptoms but does not restore the master regulatory step. Pregnenolone supplementation, by providing the precursor substrate, theoretically supports the entire downstream steroidogenic network, though the distribution between pathways remains individually variable.

4. Neurosteroid Functions of Pregnenolone

Receptor Pharmacology and Cognitive Effects

GABA-A receptor negative allosteric modulation: pregnenolone and pregnenolone sulfate reduce the efficacy of GABA at GABA-A receptors, opposing the sedating, anxiolytic, and memory-suppressing effects of GABA agonism; this explains the alerting and cognitive-enhancing properties of pregnenolone; high-dose pregnenolone can produce anxiety and insomnia through excessive GABA-A antagonism
NMDA receptor positive modulation: pregnenolone sulfate potentiates NMDA glutamate receptor activity at the sigma-1 and glycine binding sites; NMDA receptor activation is required for long-term potentiation (LTP), the synaptic plasticity mechanism underlying memory formation; NMDA potentiation by pregnenolone supports memory consolidation and cognitive performance
Sigma-1 receptor agonism: sigma-1 receptors are mitochondria-associated endoplasmic reticulum receptors with roles in neuroprotection, calcium signaling, mitochondrial bioenergetics, and neuroplasticity; pregnenolone is an endogenous sigma-1 agonist; sigma-1 activation supports neurotrophic factor production and synaptic plasticity
Memory enhancement evidence: pregnenolone at 100 to 500 mg/kg in rodent models produces dramatic memory enhancement on a wide variety of learning paradigms; human studies have been smaller but show benefits in working memory, attention, and cognitive flexibility in older adults and in patients with schizophrenia where brain neurosteroid production is reduced

Brain Aging and Neuropsychiatric Connections

Alzheimer's disease research: pregnenolone and allopregnanolone (a downstream neuroactive metabolite) are significantly reduced in the brains of Alzheimer's disease patients compared to age-matched controls; preclinical evidence suggests that restoring neurosteroid levels may reduce amyloid beta toxicity, support neurogenesis in the hippocampus, and improve memory function; brexanolone (a synthetic allopregnanolone analog) has demonstrated clinical efficacy in postpartum depression, establishing the therapeutic relevance of neurosteroid modulation
Schizophrenia and psychosis research: pregnenolone levels are reduced in cerebrospinal fluid of patients with schizophrenia; clinical trials of pregnenolone supplementation in schizophrenia have shown improvements in negative symptoms and cognitive function; the NMDA receptor hypofunction model of schizophrenia provides mechanistic rationale for pregnenolone's potential therapeutic benefit
Depression and mood regulation: pregnenolone's conversion to allopregnanolone (a potent positive allosteric GABA-A modulator) provides indirect mood-stabilizing effects; the neuroactive steroid pathway that pregnenolone enters is disrupted in major depression, PMDD, and postpartum depression; SSRI antidepressants partly work by increasing allopregnanolone production in the brain, explaining the overlap between neurosteroid modulation and antidepressant efficacy
Fatigue and cognitive fog: in functional medicine practice, patients with low pregnenolone often report mental fatigue, difficulty concentrating, word-finding difficulty, and mood flatness that responds to pregnenolone supplementation within 4 to 8 weeks; these cognitive effects are partly from direct NMDA potentiation and partly from improved DHEA and downstream hormone availability

5. Pregnenolone Supplementation: Clinical Approach

Forms and dosing: pregnenolone is available as oral capsules, sublingual drops, and topical creams; oral forms at 10 to 100mg daily are the most common starting range; sublingual administration improves bioavailability by bypassing first-pass hepatic metabolism; topical pregnenolone cream provides slower, more sustained delivery; start at 10 to 25mg daily and titrate based on symptom response and downstream hormone monitoring over 6 to 8 weeks
Morning dosing preferred: the alerting properties of pregnenolone from GABA-A antagonism and NMDA potentiation make morning dosing preferable; evening or nighttime dosing can impair sleep quality and cause vivid dreams in some patients; patients who experience daytime anxiety or irritability on pregnenolone may be converting toward androgenic pathways or may be on too high a dose
Downstream monitoring after initiation: recheck DHEA-S, testosterone, estradiol, progesterone, and cortisol at 4 to 6 weeks after starting pregnenolone supplementation; these downstream values reveal which steroidogenic pathways are being most activated by the supplemental pregnenolone substrate; unexpected elevation of any downstream hormone directs dose adjustment or addition of specific enzyme modulators
Combination with downstream hormones: pregnenolone is often used alongside direct DHEA, testosterone, or progesterone supplementation rather than as a replacement for them; pregnenolone provides substrate support across all steroidogenic branches while specific downstream hormones address defined deficiencies with more predictable target hormone effects
Contraindications and cautions: hormone-sensitive malignancies (breast, prostate, uterine cancer) are the primary contraindication; active congenital adrenal hyperplasia (where pregnenolone substrate is already shunting excessively toward androgenic pathways); known seizure disorders (NMDA potentiation may lower seizure threshold in susceptible individuals); pregnancy (teratogenic potential not established)

6. How to Support Pregnenolone Production

Mitochondrial and Adrenal Support

Pantothenic acid (vitamin B5, 500 to 1,000mg daily): B5 is required for CoA synthesis, which is essential for cholesterol transport into mitochondria and for the CYP11A1 enzymatic reaction; B5 deficiency impairs steroidogenesis at the pregnenolone synthesis step; B5 is a foundational adrenal support nutrient
CoQ10 as ubiquinol (200 to 400mg daily): the CYP11A1 enzyme requires mitochondrial electron transport chain function to provide NADPH reducing equivalents; mitochondrial dysfunction from CoQ10 deficiency impairs this electron supply and reduces pregnenolone synthesis; CoQ10 supports mitochondrial bioenergetics and thereby steroidogenesis capacity
Adequate dietary cholesterol: cholesterol is the direct substrate for pregnenolone synthesis; very low cholesterol diets (below 200mg daily) may impair steroidogenesis in some patients; dietary sources including eggs, liver, shellfish, and dairy provide bioavailable cholesterol that supports CYP11A1 substrate availability
Zinc (15 to 30mg daily): zinc is required for CYP11A1 enzyme function as a cofactor; zinc deficiency reduces steroidogenic capacity at the first and rate-limiting step; serum zinc target 80 to 110 mcg/dL
Chronic stress management: sustained HPA activation from chronic psychological or physiological stress can eventually exhaust adrenocortical steroidogenic capacity; the pregnenolone steal concept (where pregnenolone is preferentially shunted toward cortisol production at the expense of DHEA and sex hormone pathways) reflects the enzyme competition during sustained stress; managing chronic stress preserves balanced pregnenolone allocation across all steroidogenic branches

Lifestyle Foundations

Sleep optimization: the majority of adrenocortical steroidogenesis occurs during sleep; pregnenolone production is partially sleep-dependent, with growth hormone-driven increases in steroidogenic activity occurring during slow-wave sleep; 7 to 9 hours of restorative sleep in a dark cool environment supports optimal adrenal steroidogenic output
Moderate resistance exercise: resistance training acutely stimulates adrenal and gonadal steroidogenesis; regular strength training maintains steroidogenic enzyme expression and mitochondrial function in steroidogenic tissues; avoid chronic overtraining which produces sustained cortisol elevation and eventually adrenal depletion
Intermittent fasting with adequate refeeding: short-term caloric restriction activates AMPK pathways that support mitochondrial biogenesis and steroidogenic cell function; prolonged or excessive caloric restriction suppresses steroidogenesis through inadequate cholesterol and CoA substrate availability; ensure adequate dietary fat and cholesterol intake during any fasting protocol
Sauna therapy: heat stress activates heat shock proteins including HSP70 and HSP90, which are required for StAR protein function (the cholesterol shuttle into mitochondria for CYP11A1); regular sauna use may support the heat shock protein expression that facilitates cholesterol delivery to CYP11A1
Reduce environmental endocrine disruptors: phthalates, BPA, and other endocrine-disrupting chemicals impair mitochondrial steroidogenesis by interfering with StAR protein expression and CYP11A1 enzyme activity; reducing plasticizer exposure and choosing organic personal care products supports intact steroidogenic function

Neurosteroid Brain Support

Lion's mane mushroom (Hericium erinaceus, 500 to 1,000mg daily): stimulates NGF (nerve growth factor) and BDNF production; supports the neuroplasticity and cognitive function that overlaps mechanistically with pregnenolone's NMDA-potentiating neurosteroid effects; evidence for cognitive improvement in mild cognitive impairment
Omega-3 fatty acids (3 to 4g EPA and DHA daily): support neuronal membrane fluidity required for efficient neurosteroid receptor function; DHA enrichment of neuronal membranes improves NMDA receptor mobility and GABA-A receptor distribution; directly supports the synaptic environment in which pregnenolone neurosteroid effects operate
Phosphatidylserine (400mg daily): phospholipid that enriches neuronal membrane composition, supporting receptor density and synaptic transmission; clinical evidence for cognitive benefits in older adults; synergistic with pregnenolone's NMDA-potentiating effects on memory consolidation
Minimize alcohol: alcohol is a potent GABA-A positive modulator that directly opposes pregnenolone's GABA-A antagonist neurosteroid effects; chronic alcohol consumption reduces endogenous neurosteroid levels and blunts the cognitive benefits of pregnenolone supplementation; abstinence or minimal alcohol use maximizes pregnenolone's neurosteroid benefit
Address sleep apnea: chronic intermittent hypoxia from untreated sleep apnea impairs mitochondrial function in steroidogenic cells and reduces neurosteroid production in the brain; CPAP therapy improves both peripheral steroidogenesis and central neurosteroid synthesis by restoring mitochondrial oxygenation

7. Related Lab Tests

DHEA-SDirect Downstream Product of Pregnenolone via Delta-5 Pathway

→

ProgesteroneDownstream via Delta-4 Pathway; Shares Pregnenolone Precursor with Cortisol

→

CortisolDownstream Glucocorticoid from Pregnenolone via Progesterone

→

TestosteroneEnd Product of Pregnenolone via DHEA and Androstenedione Pathways

→

ACTHDrives Adrenal Pregnenolone Synthesis; Companion in HPA Axis Assessment

→

NAD+Mitochondrial Coenzyme Required for CYP11A1 Electron Transport in Pregnenolone Synthesis

→

8. Clinical Perspective

Clinical Perspective

Pregnenolone is the starting point that puts multi-hormone deficiency into a single coherent framework. When a 58-year-old man presents with low testosterone, low DHEA-S, low progesterone metabolites, and suboptimal cortisol response, the question I ask before prescribing individual replacement hormones is: what is the pregnenolone level? If it is 28 ng/dL in a man who should have a functional level of 100 to 150, then we have an upstream production problem rather than five separate hormone deficiencies, and the treatment strategy changes. Supporting mitochondrial function, providing B5, CoQ10, and zinc, and starting pregnenolone at 25 to 50mg daily alongside individual hormone optimization gives the steroidogenic cascade both the substrate it is missing and the enzymatic support it needs. I also find pregnenolone particularly compelling in the patient with documented cognitive decline or severe brain fog where the neurosteroid component, the NMDA potentiation and sigma-1 agonism, provides a direct neuroprotective mechanism that goes beyond what DHEA or testosterone supplementation alone provides. Pregnenolone occupies a unique position as both the master steroid precursor and a first-class neurosteroid in its own right, and that dual role makes it one of the most interesting molecules in functional hormone medicine.

Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma

9. Frequently Asked Questions

What is pregnenolone and why is it called the mother hormone?

Pregnenolone is a 21-carbon steroid synthesized from cholesterol in the mitochondria of steroidogenic cells in the adrenal cortex, gonads, brain, and liver. It is called the mother hormone because it is the obligatory biosynthetic precursor from which all other steroid hormones are produced. Without pregnenolone, the body cannot make cortisol, aldosterone, DHEA, testosterone, estradiol, progesterone, or any other steroid hormone. The conversion of cholesterol to pregnenolone by the CYP11A1 enzyme (also called P450scc, cholesterol side-chain cleavage) is the rate-limiting step in steroidogenesis, making pregnenolone production the master regulatory point for all downstream hormone synthesis.

What does low pregnenolone indicate?

Low serum pregnenolone, generally below 50 ng/dL in functional medicine practice, indicates reduced capacity for steroidogenesis at the master regulatory step. Common causes include advanced age (pregnenolone production declines significantly with aging), adrenal fatigue or HPA axis dysfunction where chronic stress has depleted upstream steroidogenic capacity, nutritional deficiencies (particularly cholesterol, vitamin B5, and zinc required for mitochondrial cholesterol conversion), and chronic illness that impairs adrenal function. Low pregnenolone can simultaneously reduce cortisol, DHEA, progesterone, testosterone, and estradiol production, producing a multi-hormone deficiency pattern that supplements targeting individual downstream hormones may not adequately address.

Does pregnenolone supplementation raise other hormones?

Exogenous pregnenolone theoretically should increase downstream hormone production by providing more substrate. In practice, the conversion of supplemental pregnenolone to specific downstream hormones is highly variable between individuals, depends on which enzymatic pathways are most active in a given person, and is not reliably predictable. Some people convert pregnenolone primarily toward DHEA and androgens; others toward progesterone pathways; others toward cortisol. This variability is the primary limitation of pregnenolone as a supplement: the specific hormonal effect is not consistent. Pregnenolone also has direct neurosteroid effects independent of its conversion to other hormones, acting on GABA-A, NMDA, and sigma-1 receptors with cognitive and mood-enhancing effects.

What are the neurosteroid effects of pregnenolone?

Pregnenolone is one of the most abundant neurosteroids in the human brain, produced locally by glial cells and neurons independently of peripheral adrenal production. It modulates neurotransmitter systems directly through allosteric receptor binding: it antagonizes GABA-A receptor activity (reducing the calming, sedating effects of GABA) and potentiates NMDA glutamate receptor activity (enhancing excitatory neurotransmission). These effects produce the alerting, memory-enhancing, and cognitive-supporting properties attributed to pregnenolone. Pregnenolone declines significantly in the aging brain, and this decline has been associated with cognitive decline, memory impairment, and mood changes. Supplemental pregnenolone in some clinical studies improves measures of working memory, attention, and cognitive flexibility in older adults.

Is pregnenolone supplementation safe?

Pregnenolone supplementation at typical doses of 10 to 100mg daily is generally well-tolerated in healthy adults. Because pregnenolone is a hormone precursor, its conversion to downstream hormones introduces the same theoretical concerns as direct hormone supplementation: androgenic effects from DHEA and testosterone conversion (acne, hair loss, hirsutism in susceptible individuals), estrogenic effects from estrogen pathway conversion, and stimulating effects from neurosteroid NMDA potentiation (anxiety, irritability, insomnia at higher doses). Monitoring DHEA-S, testosterone, estradiol, and progesterone after 4 to 6 weeks of pregnenolone supplementation allows assessment of which downstream pathways are being most activated in a given individual. Pregnenolone should be used with caution in patients with hormone-sensitive cancers, active adrenal hyperplasia, or personal history of seizures.

Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.

Pregnenolone is the master steroid precursor and a potent neurosteroid. Low levels create multi-hormone deficiency patterns and cognitive impairment that neither individual hormone replacement nor cognitive supplements alone address.

Pregnenolone is part of a comprehensive steroidogenesis assessment at The Lamkin Clinic. Schedule a consultation for a complete upstream hormone evaluation and personalized steroid hormone optimization plan.

Schedule a Consultation

Medical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.